This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ramachandran, V. Articles by Logsdon, C. D. Search for Related Content PubMed PubMed Citation Articles by Ramachandran, V. Articles by Logsdon, C. D.

Adrenomedullin Is Expressed in Pancreatic Cancer and Stimulates Cell Proliferation and Invasion in an Autocrine Manner via the Adrenomedullin Receptor, ADMR

Departments of ¹ Cancer Biology, ² Medical Oncology, and ³ Surgical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, Texas; and Departments of ⁴ Pathology and ⁵ Surgery, University of Michigan, Ann Arbor, Michigan

Requests for reprints: Craig D. Logsdon, Departments of Cancer Biology and Medical Oncology, University of Texas M. D. Anderson Cancer Center, Unit 905, 1515 Holcombe Boulevard, Houston, TX 77030. Phone: 713-563-3585; Fax: 713-563-8986; E-mail: clogsdon{at}mdanderson.org.

The current study investigated adrenomedullin as a potential autocrine regulator of pancreatic cancer cell function. Adrenomedullin was localized in the neoplastic epithelium of 90% (43 of 48) of human pancreatic adenocarcinomas analyzed by immunohistochemistry and was expressed by 100% (8 of 8) of pancreatic cancer cell lines analyzed by reverse transcription-PCR. Pancreatic cancer cell lines also secreted adrenomedullin into the culture medium as determined by ELISA (5 of 5). Exogenous adrenomedullin treatment of Panc-1, BxPC3, and MPanc96 cells in vitro stimulated cell proliferation, invasion, and nuclear factor B activity, indicating the ability of the cells to respond to adrenomedullin. Treatment of the cell cultures with an adrenomedullin antagonist inhibited basal levels of proliferation and nuclear factor B activity, supporting the autocrine function of this molecule. Furthermore, increasing adrenomedullin levels by gene transfer to Panc-1 cells increased, whereas adrenomedullin small hairpin RNA silencing in MPanc96 cells inhibited tumor growth and metastasis in vivo. Adrenomedullin is able to act through at least two different receptors, adrenomedullin receptor (ADMR) and calcitonin receptor–like receptor (CRLR). Reverse transcription-PCR and Western blotting indicated that pancreatic cancer cells expressed only ADMR but not CRLR. In contrast, cells found in the tumor microenvironment, primary human pancreatic stellate and endothelial (HUVEC) cells, expressed both ADMR and CRLR. Small hairpin RNA silencing of ADMR in pancreatic cancer cells blocked adrenomedullin-induced growth and invasion, indicating that this receptor is involved in the autocrine actions of adrenomedullin. These data indicate that adrenomedullin acting via ADMR increases the aggressiveness of pancreatic cancer cells and suggests that these molecules may be useful therapeutic targets. [Cancer Res 2007;67(6):2666–75]

This article has been cited by other articles:

				I. Kaafarani, S. Fernandez-Sauze, C. Berenguer, O. Chinot, C. Delfino, C. Dussert, P. Metellus, F. Boudouresque, K. Mabrouk, F. Grisoli, et al. Targeting adrenomedullin receptors with systemic delivery of neutralizing antibodies inhibits tumor angiogenesis and suppresses growth of human tumor xenografts in mice FASEB J, October 1, 2009; 23(10): 3424 - 3435. [Abstract] [Full Text] [PDF]

				V. Ramachandran, T. Arumugam, H. Wang, and C. D. Logsdon Anterior Gradient 2 Is Expressed and Secreted during the Development of Pancreatic Cancer and Promotes Cancer Cell Survival Cancer Res., October 1, 2008; 68(19): 7811 - 7818. [Abstract] [Full Text] [PDF]